Compare ATRC & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | PHIN |
|---|---|---|
| Founded | 2000 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2005 | 2023 |
| Metric | ATRC | PHIN |
|---|---|---|
| Price | $57.29 | $56.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $54.89 | ★ $91.60 |
| AVG Volume (30 Days) | ★ 1.4M | 428.7K |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | 74.74 | ★ 84.09 |
| EPS | 0.18 | ★ 2.01 |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $13.42 | $4.59 |
| Revenue Next Year | $12.12 | $3.61 |
| P/E Ratio | $307.50 | ★ $28.68 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $50.80 |
| 52 Week High | $61.70 | $86.94 |
| Indicator | ATRC | PHIN |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 26.91 |
| Support Level | $26.95 | N/A |
| Resistance Level | $61.70 | $81.54 |
| Average True Range (ATR) | 2.50 | 1.60 |
| MACD | -0.68 | 0.08 |
| Stochastic Oscillator | 55.81 | 2.47 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.